Dobutamine Injection
Product Images NDC 70436-203

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dobutamine (NDC 70436-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dubutamine 1 (Ee09a55f 9992 48bb B8d6 1184bd548536 00)

Chemical structure of dobutamine hydrochloride showing two benzene rings each substituted with hydroxyl groups and an amine side chain linking them.*

FDA Label Image

70436-203-80 (Image 01)

Dobutamine Injection, USP 250 mg/20 mL (12.5 mg/mL) single-dose vial label for intravenous use. The label states the product is manufactured by Hainan Poly Pharm. Co., Ltd. in China and distributed by Slate Run Pharmaceuticals, LLC, Columbus, Ohio. It includes dilution instructions, storage conditions, and a barcode. The label emphasizes that the drug must be diluted prior to use and used within 24 hours after dilution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.